Pulse Biosciences Announces Completion Of 164-Patient Enrollment In Pivotal Atrial Fibrillation Study Of nPulse Catheter, Three Months Ahead Of Schedule

Benzinga Newsdesk www.benzinga.com Positive 66.8%